PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA.\', \'Southwest National Primate Research Center, Texas Biomedical Research Institute, San Antonio, TX 78245, USA.\', \'Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA. Electronic address: christos.kyratsous@regeneron.com.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0092-8674(21)00703-010.1016/j.cell.2021.06.002
?:hasPublicationType
?:journal
  • Cell
is ?:pmid of
?:pmid
?:pmid
  • 34161776
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 25.137
?:rankingScore_hIndex
  • 682
?:title
  • The monoclonal antibody combination REGEN-COV protects against SARS-CoV-2 mutational escape in preclinical and human studies.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all